About The Scoliosis Brace

Scoliosis bracing and the SpineCor Brace

Please be advised, the Spinecorporation LTD manufactures the Spinecor brace and only recommends its use for Adolescent Idiopathic Scoliosis.  Any other treatments or appropriate therapy provided by our doctors is in no way affiliated with the Spinecorporation LTD. Drs. Lamantia and Deutchman may accept cases which do not meet the inclusion criteria set forth by the Spinecorporation LTD.

Click here to read Spinecor paper 2007 Journal of Pediatric Orthopedics

Abstract:
SpineCor – a non-rigid brace for the treatment of idiopathic scoliosis: post-treatment results (Euro Spine 2004)

At 2 years follow-up there was an overall correction of greater than 5° for 55% of the patients, 38% had a stabilization and 7% had worsened by more than 5°. This initial cohort of patients demonstrated a general trend of initial decrease in spinal curvature in brace, followed by a correction and/or stabilization at the end of treatment, which was maintained through 1, and 2 years’ follow-up.

SpineCor is the first dynamic flexible brace for the treatment of idiopathic scoliosis. Although the developers of SpineCor only treat children, Scoliosis Systems (TM), the largest provider of SpineCor in the United States, has designed protocols for the use of the SpineCor brace with adults.

SpineCor Brace Survival Analysis of a Group of 365 Idiopathic Scoliosis Patients (SRS 2005)

Charles H. Rivard M.D. et al.

Summary: 365 idiopathic scoliosis patients have been treated by the SpineCor System. They have been categorized before treatment into two groups according to their initial Cobb angle, the first having a curve from 15 to 29 degrees and the other having a curve of 30 degrees and more. At five years post weaning, we achieved 96.2% of success and 3.8% of worsening.

Purpose: The objective of this study is to show the effectiveness of the SpineCor system dedicated to the treatment of the idiopathic scoliosis.

Methods: 365 idiopathic scoliosis patients treated by the SpineCor System was followed at Sainte- Justine Hospital. The patients cohort was categorized before treatment into two groups according to their initial Cobb angle: group 1 (15 to 29 degrees) and group 2 (30 degrees and more). A survival analysis was carried out in order to evaluate the cumulative probability of success during the treatment, the follow-up and for the period combining the treatment and the follow-up. Success was defined as either stabilization or a reduction of 5º or more of the initial Cobb angle and failure as a worsening of more than 5º.

Results: The survival analysis indicated a cumulative probability of success that is stable during the post-treatment follow-up period (Year 1: 0.97, .093; Year 2: 0.94, 0.88; Year 3: 0.91, 0.84; Year 4: 0.79, 0.84. for the group 1 and 2 respectively). There is an overall probability of success of 0.97 and 0.83 at 4 years; 0.85 and 0.61 at 7 years for group 1 and group 2 respectively of combined treatment and post treatment follow-up. At five years post weaning there was a permanent correction for 65.4% of the patients, 30.8% had a stabilization and 3.8% had worsened.

Conclusion: Because of the progressive reduction of the pathological defects, owing to the fact that SpineCor system does not offer any effect of distraction or support and of maintains of an effective musculature, there is only one very small percentage (3.8 %) of loss of correction 5 years after the end of bracing.

Significance: The conservative treatment with SpineCor brace in A.I.S. is efficient.

Trackback URL for this entry